SynthesisBMC psychiatry2025
Relapse and associated factors among psychiatric patients in Africa: a systematic review and meta-analysis.
Synthesis in BMC psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Clinical outcomes in first-episode schizophrenia: identifying predictors of relapse.Social psychiatry and psychiatric epidemiology · 2026Article
- Predictors of psychological symptom risk in older adults in Türkiye: the role of mental health literacy and demographic-clinical factors.BMC geriatrics · 2026Article
- Prevalence, Predictors, and Moderators of Relapse in Severe Mental Disorders: Evidence from Ndera Neuropsychiatric Teaching Hospital, Rwanda.Rwanda journal of medicine and health sciences · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRelapse refers to the deterioration or recurrence of a patient's previous illness after either partial or full recovery. It is commonly observed in various mental disorders, with relapse rates ranging from 50 to 92%. This phenomenon can adversely affect the prognosis of the disorder, the functionality of individuals, and may even increase the overall costs of treatment. To achieve the desired outcomes in psychiatric treatment, it is crucial to prevent relapse whenever possible. Evidence-based data is essential for this purpose. This systematic review and meta-analysis provide an estimated pooled effect size of relapse and its determinants within this population, thereby guiding the development of appropriate intervention plans.
methodsObservational studies on relapse and its contributing factors among African individuals living with mental illness were included based on predetermined criteria following independent evaluations by two authors. Multiple databases, including PubMed, African Journals Online, ScienceDirect, and EMBASE, were utilized to ensure comprehensive coverage of relevant studies. The data extracted using Microsoft Excel were imported into STATA version 14 for further analysis. Funnel plots and Egger regression tests were employed to assess the presence of publication bias. Additionally, subgroup analysis and sensitivity analysis were conducted.
resultsThis systematic review and meta-analysis included sixteen research articles involving 4,660 participants. The pooled prevalence of relapse among individuals with mental health disorders was found to be 60.66% (95% CI: 50.00-70.26). A regional subgroup analysis revealed that the southern region of Africa exhibited the highest relapse rate at 74.05%, while the eastern region recorded the lowest rate at 56.08%. Factors associated with relapse included medication non-adherence [AOR = 3.09 (2.05, 4.66)] and comorbidity of mental illness [AOR = 2.45 (1.41, 4.27)]. CONCLUSION AND RECOMMENDATION: Overall, the results of our review indicated that six out of ten individuals with mental illnesses experienced a relapse. Factors associated with relapse included non-adherence to medication and the presence of comorbid mental health conditions. Therefore, it would be beneficial for mental health care providers to discuss the reasons for relapse with patients and their families in order to prevent these occurrences.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.